Written By Vanessa Kariuki ||
A World Health Organisation (WHO) delegation was hosted by the Pharmacy and Poisons Board to talk about local production and strengthening regulatory systems.
To save costs and guarantee access for all citizens, Kenya has set its eyes on becoming a major regional centre for the manufacture of pharmaceuticals and healthcare equipment.
Dr Charles Githinji, the PPB’s chairman, stressed the significance of local manufacturing during the WHO delegation’s visit, emphasising how it is essential for all Kenyans to have access to cheap healthcare.
In keeping with the “Bottom Up Economic Transformation Agenda” outlined in the Kenya Kwanza Manifesto, the Chairman reaffirmed the government’s commitment to fostering domestic pharmaceutical production.
According to reports from Fitch and the World Bank, Kenya is a promising market for medical equipment and has one of the fastest-growing economies in sub-Saharan Africa.
Whether via direct manufacture or indirectly through local distribution channels, the pharmaceutical industry in Kenya is expanding quickly and presents tremendous chances for businesses to develop their goods and services.
With nearly 50% of the COMESA region’s market supplied by Kenya, the country is currently the top manufacturer of pharmaceutical goods.
